DE69937447T2 - Verfahren zur erkennung von nukleinsäuren - Google Patents
Verfahren zur erkennung von nukleinsäuren Download PDFInfo
- Publication number
- DE69937447T2 DE69937447T2 DE69937447T DE69937447T DE69937447T2 DE 69937447 T2 DE69937447 T2 DE 69937447T2 DE 69937447 T DE69937447 T DE 69937447T DE 69937447 T DE69937447 T DE 69937447T DE 69937447 T2 DE69937447 T2 DE 69937447T2
- Authority
- DE
- Germany
- Prior art keywords
- target
- sequence
- nucleic acid
- labeled
- oligonucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims abstract description 79
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 77
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 70
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 70
- 238000001514 detection method Methods 0.000 claims abstract description 67
- 238000002372 labelling Methods 0.000 claims abstract description 66
- 108020005187 Oligonucleotide Probes Proteins 0.000 claims abstract description 50
- 239000002751 oligonucleotide probe Substances 0.000 claims abstract description 50
- 239000002773 nucleotide Substances 0.000 claims abstract description 46
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 46
- 230000000295 complement effect Effects 0.000 claims abstract description 40
- 108091034117 Oligonucleotide Proteins 0.000 claims abstract description 33
- 238000009396 hybridization Methods 0.000 claims abstract description 21
- 230000027455 binding Effects 0.000 claims abstract description 19
- 239000000523 sample Substances 0.000 claims description 99
- 238000006243 chemical reaction Methods 0.000 claims description 46
- 230000003321 amplification Effects 0.000 claims description 36
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 36
- 241000192700 Cyanobacteria Species 0.000 claims description 18
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 17
- 239000012528 membrane Substances 0.000 claims description 16
- 238000010348 incorporation Methods 0.000 claims description 15
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 14
- 241000894006 Bacteria Species 0.000 claims description 10
- 239000005546 dideoxynucleotide Substances 0.000 claims description 10
- 239000007787 solid Substances 0.000 claims description 10
- 238000004925 denaturation Methods 0.000 claims description 3
- 230000036425 denaturation Effects 0.000 claims description 3
- 230000008685 targeting Effects 0.000 claims 1
- 238000012207 quantitative assay Methods 0.000 abstract description 4
- 230000002906 microbiologic effect Effects 0.000 abstract description 2
- 238000012205 qualitative assay Methods 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 61
- 238000003556 assay Methods 0.000 description 48
- 210000004027 cell Anatomy 0.000 description 46
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 27
- 239000002585 base Substances 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 230000002860 competitive effect Effects 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 241000192701 Microcystis Species 0.000 description 11
- 125000004122 cyclic group Chemical group 0.000 description 11
- 230000007613 environmental effect Effects 0.000 description 11
- 238000000746 purification Methods 0.000 description 11
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 10
- 238000011534 incubation Methods 0.000 description 10
- 239000007790 solid phase Substances 0.000 description 10
- 108091093088 Amplicon Proteins 0.000 description 9
- 239000011324 bead Substances 0.000 description 9
- 238000011002 quantification Methods 0.000 description 9
- 238000000926 separation method Methods 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 8
- 108020004465 16S ribosomal RNA Proteins 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 108020004999 messenger RNA Proteins 0.000 description 7
- 238000012544 monitoring process Methods 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 241000894007 species Species 0.000 description 7
- 239000003053 toxin Substances 0.000 description 7
- 231100000765 toxin Toxicity 0.000 description 7
- 108700012359 toxins Proteins 0.000 description 7
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 235000011178 triphosphate Nutrition 0.000 description 6
- 239000001226 triphosphate Substances 0.000 description 6
- 241000192542 Anabaena Species 0.000 description 5
- 241000107857 Microcystis aeruginosa PCC 7005 Species 0.000 description 5
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 5
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 238000013207 serial dilution Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 241000192660 Aphanizomenon Species 0.000 description 4
- 239000002028 Biomass Substances 0.000 description 4
- 241000531083 Dolichospermum lemmermannii Species 0.000 description 4
- 241000192710 Microcystis aeruginosa Species 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 108010058966 bacteriophage T7 induced DNA polymerase Proteins 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000004069 differentiation Effects 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000007837 multiplex assay Methods 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 102000054765 polymorphisms of proteins Human genes 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 238000003260 vortexing Methods 0.000 description 4
- OAKPWEUQDVLTCN-NKWVEPMBSA-N 2',3'-Dideoxyadenosine-5-triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO[P@@](O)(=O)O[P@](O)(=O)OP(O)(O)=O)O1 OAKPWEUQDVLTCN-NKWVEPMBSA-N 0.000 description 3
- 102100034343 Integrase Human genes 0.000 description 3
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 3
- 241000192656 Nostoc Species 0.000 description 3
- 241000530613 Pseudanabaena limnetica Species 0.000 description 3
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 230000001351 cycling effect Effects 0.000 description 3
- URGJWIFLBWJRMF-JGVFFNPUSA-N ddTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)CC1 URGJWIFLBWJRMF-JGVFFNPUSA-N 0.000 description 3
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 3
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 238000001502 gel electrophoresis Methods 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 229960004198 guanidine Drugs 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000005291 magnetic effect Effects 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000002966 oligonucleotide array Methods 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 3
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 3
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
- 239000005695 Ammonium acetate Substances 0.000 description 2
- 241001316054 Aphanizomenon gracile NIVA-CYA 103 Species 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000191358 Chlorobium sp. Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- 241000610595 Microcystis cf. aeruginosa NIVA-CYA 144 Species 0.000 description 2
- 241000192673 Nostoc sp. Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 241000192605 Phormidium sp. Species 0.000 description 2
- 241000530769 Planktothrix Species 0.000 description 2
- 241000048846 Planktothrix agardhii NIVA-CYA 29 Species 0.000 description 2
- 108020001027 Ribosomal DNA Proteins 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 229940043376 ammonium acetate Drugs 0.000 description 2
- 235000019257 ammonium acetate Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 229960000633 dextran sulfate Drugs 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000013024 dilution buffer Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000012252 genetic analysis Methods 0.000 description 2
- 231100000334 hepatotoxic Toxicity 0.000 description 2
- 230000003082 hepatotoxic effect Effects 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000007834 ligase chain reaction Methods 0.000 description 2
- 239000012139 lysis buffer Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 230000005298 paramagnetic effect Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 239000011535 reaction buffer Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- 241001479434 Agfa Species 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 241001464430 Cyanobacterium Species 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010056740 Genital discharge Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 108010049746 Microcystins Proteins 0.000 description 1
- 241001316831 Microcystis aeruginosa NIVA-CYA 143 Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 238000002944 PCR assay Methods 0.000 description 1
- 241000530778 Planktothrix prolifica Species 0.000 description 1
- 241000048830 Planktothrix rubescens NIVA-CYA 320 Species 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- ARLKCWCREKRROD-POYBYMJQSA-N [[(2s,5r)-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)CC1 ARLKCWCREKRROD-POYBYMJQSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000002380 cytological effect Effects 0.000 description 1
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical group NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000014670 detection of bacterium Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- -1 filters Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 210000001990 heterocyst Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000007431 microscopic evaluation Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9807045 | 1998-04-01 | ||
| GBGB9807045.1A GB9807045D0 (en) | 1998-04-01 | 1998-04-01 | Nucleic acid detection method |
| PCT/GB1999/001025 WO1999050448A2 (en) | 1998-04-01 | 1999-04-01 | Nucleic acid detection method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69937447D1 DE69937447D1 (de) | 2007-12-13 |
| DE69937447T2 true DE69937447T2 (de) | 2008-08-21 |
Family
ID=10829712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69937447T Expired - Lifetime DE69937447T2 (de) | 1998-04-01 | 1999-04-01 | Verfahren zur erkennung von nukleinsäuren |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US6617138B1 (https=) |
| EP (1) | EP1068352B1 (https=) |
| JP (1) | JP4481491B2 (https=) |
| CN (1) | CN100381576C (https=) |
| AT (1) | ATE377091T1 (https=) |
| AU (1) | AU769566B2 (https=) |
| CA (1) | CA2325052C (https=) |
| DE (1) | DE69937447T2 (https=) |
| GB (1) | GB9807045D0 (https=) |
| NO (1) | NO326359B1 (https=) |
| WO (1) | WO1999050448A2 (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10012540B4 (de) * | 2000-03-15 | 2004-09-23 | Vermicon Ag | Oligonukleotide und Verfahren zum spezifischen Nachweis von Mikroorganismen durch Polymerase-Kettenreaktion |
| US7732138B2 (en) * | 2001-11-07 | 2010-06-08 | Diagcor Bioscience Incorporation Limited | Rapid genotyping analysis and the device thereof |
| ATE533419T1 (de) * | 2003-05-17 | 2011-12-15 | Depuy Int Ltd | Marknagel-system |
| FI20030771A7 (fi) * | 2003-05-21 | 2004-11-22 | Helsingin Yliopisto | Menetelmä toksisten syanobakteerien määrittämiseksi |
| US7338763B2 (en) | 2004-06-02 | 2008-03-04 | Eppendorf Array Technologies S.A. | Method and kit for the detection and/or quantification of homologous nucleotide sequences on arrays |
| US20060057611A1 (en) | 2004-06-30 | 2006-03-16 | Applera Corporation | Log-linear amplification |
| FR2873388B1 (fr) * | 2004-07-23 | 2012-04-06 | Biomerieux Sa | Procede de marquage et de purification d'acides nucleiques d'interet presents dans un echantillon biologique a traiter dans un unique recipient reactionnel |
| CA2596495A1 (en) * | 2005-02-09 | 2006-08-17 | Pacific Biosciences Of California, Inc. | Nucleotide compositions and uses thereof |
| US7964413B2 (en) | 2005-03-10 | 2011-06-21 | Gen-Probe Incorporated | Method for continuous mode processing of multiple reaction receptacles in a real-time amplification assay |
| WO2006128230A1 (en) * | 2005-05-31 | 2006-12-07 | Newsouth Innovations Pty Limited | Detection of hepatotoxic cyanobacteria |
| EP2334808B1 (en) * | 2008-10-01 | 2017-11-15 | Koninklijke Philips N.V. | Method for testing and quality controlling of nucleic acids on a support |
| GB2475226A (en) | 2009-11-03 | 2011-05-18 | Genetic Analysis As | Universal Prokaryote 16S ribosome PCR primer pair |
| US9046507B2 (en) | 2010-07-29 | 2015-06-02 | Gen-Probe Incorporated | Method, system and apparatus for incorporating capacitive proximity sensing in an automated fluid transfer procedure |
| GB201021399D0 (en) | 2010-12-16 | 2011-01-26 | Genetic Analysis As | Oligonucleotide probe set and methods of microbiota profiling |
| GB201021397D0 (en) | 2010-12-16 | 2011-01-26 | Genetic Analysis As | Diagnosis of Crohn's disease |
| GB201102693D0 (en) | 2011-02-16 | 2011-03-30 | Genetic Analysis As | Method for identifying neonates at risk for necrotizing enterocolitis |
| AU2012222178B2 (en) | 2011-02-24 | 2014-12-18 | Gen-Probe Incorporated | Systems and methods for distinguishing optical signals of different modulation frequencies in an optical signal detector |
| GB201110712D0 (en) | 2011-06-23 | 2011-08-10 | Univ Ulster | Diagnostic methods |
| DE102012204366B4 (de) * | 2011-12-16 | 2017-07-27 | Siemens Aktiengesellschaft | Verfahren und Kit zur Identifizierung und Quantifizierung von einer einzelsträngigen Ziel-Nukleinsäure |
| GB201501603D0 (en) | 2015-01-30 | 2015-03-18 | Norwegian University Of Life Sciences And Hedmark University College | Method and product |
| PL3593139T3 (pl) | 2017-03-07 | 2025-11-17 | Elypta Ab | Biomarkery nowotworowe |
| CN107287291B (zh) * | 2017-06-02 | 2021-01-05 | 华南师范大学 | 一种基于g-C3N4与CdTe/CdS量子点相互作用的双标记核酸检测方法 |
| WO2019200326A1 (en) | 2018-04-13 | 2019-10-17 | Rarecyte, Inc. | Kits for labeling of biomarkers and methods of using the same |
| EP3921325A4 (en) * | 2019-02-08 | 2022-11-23 | Board of Regents, The University of Texas System | ISOLATION AND DETECTION OF AN EXOSOME-ASSOCIATED MICROBIOME FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES |
| CN110878298B (zh) * | 2019-11-22 | 2023-09-15 | 深圳市易基因科技有限公司 | rRNA捕获探针及其应用 |
| EP4413164A1 (en) | 2021-10-04 | 2024-08-14 | Age Labs AS | Screening method for rheumatoid arthritis |
| WO2024008955A1 (en) | 2022-07-08 | 2024-01-11 | Age Labs As | Method of screening for severe covid-19 susceptibility |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5710028A (en) * | 1992-07-02 | 1998-01-20 | Eyal; Nurit | Method of quick screening and identification of specific DNA sequences by single nucleotide primer extension and kits therefor |
| BR9306867A (pt) * | 1992-07-17 | 1998-12-08 | Aprogenex Inc | Enriquecimento e identificação de células fetais do sangue materno para a hibridização in situ |
| WO1994009156A1 (en) * | 1992-10-08 | 1994-04-28 | The Regents Of The University Of California | Pcr assays to determine the presence and concentration of a target |
| WO1997032044A1 (en) * | 1996-03-01 | 1997-09-04 | E.I. Du Pont De Nemours And Company | A method for the amplification and detection of a nucleic acid fragment of interest |
| DE19612684A1 (de) * | 1996-03-29 | 1997-10-02 | Gsf Forschungszentrum Umwelt | Neue Verwendung extrem thermophiler DNA-Polymerasen |
-
1998
- 1998-04-01 GB GBGB9807045.1A patent/GB9807045D0/en not_active Ceased
-
1999
- 1999-04-01 US US09/646,847 patent/US6617138B1/en not_active Expired - Lifetime
- 1999-04-01 AU AU33389/99A patent/AU769566B2/en not_active Ceased
- 1999-04-01 WO PCT/GB1999/001025 patent/WO1999050448A2/en not_active Ceased
- 1999-04-01 CN CNB998048712A patent/CN100381576C/zh not_active Expired - Lifetime
- 1999-04-01 EP EP99914659A patent/EP1068352B1/en not_active Expired - Lifetime
- 1999-04-01 JP JP2000541335A patent/JP4481491B2/ja not_active Expired - Lifetime
- 1999-04-01 DE DE69937447T patent/DE69937447T2/de not_active Expired - Lifetime
- 1999-04-01 CA CA2325052A patent/CA2325052C/en not_active Expired - Lifetime
- 1999-04-01 AT AT99914659T patent/ATE377091T1/de not_active IP Right Cessation
-
2000
- 2000-10-02 NO NO20004962A patent/NO326359B1/no not_active IP Right Cessation
-
2003
- 2003-09-09 US US10/658,100 patent/US20040197794A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1068352B1 (en) | 2007-10-31 |
| CA2325052C (en) | 2011-08-02 |
| WO1999050448A3 (en) | 1999-12-02 |
| WO1999050448A2 (en) | 1999-10-07 |
| US20040197794A1 (en) | 2004-10-07 |
| AU3338999A (en) | 1999-10-18 |
| EP1068352A2 (en) | 2001-01-17 |
| CA2325052A1 (en) | 1999-10-07 |
| NO20004962L (no) | 2000-12-01 |
| DE69937447D1 (de) | 2007-12-13 |
| AU769566B2 (en) | 2004-01-29 |
| JP4481491B2 (ja) | 2010-06-16 |
| CN1308685A (zh) | 2001-08-15 |
| CN100381576C (zh) | 2008-04-16 |
| JP2003516710A (ja) | 2003-05-20 |
| ATE377091T1 (de) | 2007-11-15 |
| NO20004962D0 (no) | 2000-10-02 |
| US6617138B1 (en) | 2003-09-09 |
| NO326359B1 (no) | 2008-11-17 |
| GB9807045D0 (en) | 1998-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69937447T2 (de) | Verfahren zur erkennung von nukleinsäuren | |
| DE69225333T2 (de) | Verfahren für den Nachweis von Mikroorganismen unter verwendung von direkter undwillkürlicher DNA Amplifikation. | |
| DE69231646T2 (de) | Fingerabdruckartige identifikation von bakterienstämmen mittels amplifikation repetitiver dna-sequenzen | |
| DE69003477T2 (de) | Verfahren zum Nachweis von Nucleinsäuren. | |
| DE112013004650T5 (de) | Multiplexpyrosequenzierung unter Verwendung nichtinterferierender, rauschbeendender Polynukleotididentifikationstags | |
| DE102004036285A1 (de) | Verfahren zum Bestimmen der Häufigkeit von Sequenzen einer Probe | |
| DE69231961T2 (de) | Oligonucleotide zum Nachweis von Vibrio parahaemolyticus | |
| JP2003516710A5 (https=) | ||
| DE19515891C2 (de) | Gattungs- und speziesspezifische Identifizierung von Legionellen | |
| DE60038109T2 (de) | Verfahren zur Analyse von AFLP Reaktionsmischungen unter Verwendung von Primer Verlängerungstechniken | |
| DE112020000525B4 (de) | Verfahren zum nachweis mehrerer ziele basierend auf einer einzigen nachweissonde unter verwendung eines markierungs-sequenz-snp | |
| DE69527328T2 (de) | NUKLEINSÄUREPROBEN ZUR DETEKTION VON -i(HAEMOPHILUS INFLUENZA) | |
| DE69022362T2 (de) | Nukleinsäuresonden für die detektion von neisseria gonorrhoeae. | |
| DE60114816T2 (de) | Umgekehrter nachweis zur identifizierung und/oder quantifizierung von nukleotid-zielsequenzen mittels biochips | |
| EP1366189A2 (de) | Nachweis von pathogenen bakterien | |
| DE69631413T2 (de) | Nachweis einer bakterie der pectinatus gattung | |
| DE10392538B4 (de) | Verfahren zur Analyse von methylierten Nukleinsäuren | |
| EP1490507B1 (de) | Verfahren zum nachweis von mikroorganismen mittels in situ-hybridisierung und durchflusszytometrie | |
| DE60024679T2 (de) | Methoden und zusammensetzungen zur detektion von spezies des mycobacterium avium-komplexes | |
| EP1606420B1 (de) | Verfahren und kit zum spezifischen nachweis von m. tuberculosis | |
| EP2129798A2 (de) | Organismusspezifisches hybridisierbares nucleinsäuremolekül | |
| DE60207036T2 (de) | Detektionsverfahren für Escherichia coli | |
| DE102005060090B4 (de) | Nachweis von coliformen Bakterien | |
| DE19914461A1 (de) | Verfahren zur Amplifikation von DNA-Fragmenten, Gerät zur Amplifikation von DNA-Fragmenten, Verfahren zum Testen auf Mikroorganismen, Verfahren zur Analyse von Mikroorganismen und Verfahren zum Testen auf eine Verunreinigung | |
| WO2014015925A1 (de) | Verfahren zur differenzierung zwischen lebenden und toten zellen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8327 | Change in the person/name/address of the patent owner |
Owner name: GENETIC ANALYSIS AS, AS, NO |